DermTech Funding & Investors

DermTech, Inc. produces and distributes specialty pharmaceutical products. The Company offers medicines for early detection of skin cancer and nflammatory diseases. DermTech serves patients in the United States.

Total Amount Raised: $259,860,640

DermTech Funding Rounds

Post Ipo Equity
$143,700,000
Jan 5, 2021
Post Ipo Equity
$65,000,000
Mar 1, 2020
Series Unknown
$4,000,000
Jul 31, 2019
Series Unknown Investors
HLM Venture Partners
Series C
$10,000,000
Oct 31, 2017
Series Unknown
$2,065,999
Oct 20, 2016
Series Unknown
$4,314,872
Nov 12, 2015
Debt Financing
$2,441,068
Apr 13, 2015
Series B
$5,600,000
Aug 19, 2013
Series Unknown
$11,580,000
Apr 9, 2012
Series Unknown
$11,158,700
Mar 23, 2008
Post Ipo Equity
$143,700,000
Jan 5, 2021
Post Ipo Equity
$65,000,000
Mar 1, 2020
Series Unknown
$4,000,000
Jul 31, 2019
Series Unknown Investors
HLM Venture Partners
Series Unknown
$2,065,999
Oct 20, 2016
Series Unknown
$4,314,872
Nov 12, 2015
Debt Financing
$2,441,068
Apr 13, 2015
Series B
$5,600,000
Aug 19, 2013
Series Unknown
$11,580,000
Apr 9, 2012
Series Unknown
$11,158,700
Mar 23, 2008
Post Ipo Equity
$65,000,000
Mar 1, 2020
Series Unknown
$4,000,000
Jul 31, 2019
Series Unknown Investors
HLM Venture Partners
Debt Financing
$2,441,068
Apr 13, 2015
Series B
$5,600,000
Aug 19, 2013
Series Unknown
$11,580,000
Apr 9, 2012
Series Unknown
$11,158,700
Mar 23, 2008
Series C
$10,000,000
Oct 31, 2017
Series Unknown
$2,065,999
Oct 20, 2016
Series Unknown
$4,314,872
Nov 12, 2015

Funding info provided by Diffbot.